Learn more

TIANJIN SCIPHARMACN LTD

Overview
  • Total Patents
    13
  • GoodIP Patent Rank
    194,103
About

TIANJIN SCIPHARMACN LTD has a total of 13 patent applications. Its first patent ever was published in 2012. It filed its patents most often in China. Its main competitors in its focus markets macromolecular chemistry and polymers, textiles and paper and machines are ONISHI HIDEAKI, SUZHOU OMAY OPTICAL MATERIALS CO LTD and SHENZHEN YUANFANG TECH NEW MATERIAL CO LTD.

Patent filings in countries

World map showing TIANJIN SCIPHARMACN LTDs patent filings in countries
# Country Total Patents
#1 China 13

Patent filings per year

Chart showing TIANJIN SCIPHARMACN LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Tian Dongkui 9
#2 He Lei 6
#3 Li Junwei 4
#4 Liu Zhifeng 3

Latest patents

Publication Filing date Title
CN111303534A Special rare earth/polypropylene composite master batch for melt-blowing, melt-blown fabric and preparation method thereof
CN106177677A A kind of for assisting the medicine of chemoembolization of hepatic carcinoma
CN106177611A One treats leukemic Chinese medicine and application thereof
CN105796398A Whitening sterilization hand cleanser and preparation method thereof
CN105794799A Application of paralytic shellfish poisoning (PSP) toxin to preparation of medicament for controlling Blattella germanica
CN102952020A Method for preparing single or dual-alkyl substitution product of propane diamine
CN102952137A Preparation method of 2,4-diamino-6-bromomethyl pteridine
CN102952086A Preparation method of 2-morpholinyl-substituted pyrimidine compounds
CN102952025A Preparation method of (S)-1-amino-3-chloro-2-propyl alcohol hydrochloride
CN102951978A Method for reducing acid into alcohol by sodium borohydride
CN102951851A Rare earth doping zinc oxide nano-array/hollow glass microbead composite structure and preparation method thereof
CN102949867A High-efficiency antifoaming agent
CN102952364A Toughening method for waste ABS (acrylonitrile butadiene styrene)